Literature DB >> 21822708

Association between deteriorated renal function and long-term clinical outcomes after percutaneous coronary intervention.

Manabu Ogita1, Kenichi Sakakura, Tomohiro Nakamura, Hiroshi Funayama, Hiroshi Wada, Ryo Naito, Yoshitaka Sugawara, Norifumi Kubo, Junya Ako, Shin-ichi Momomura.   

Abstract

Acute renal insufficiency after percutaneous coronary artery intervention (PCI) is a strong predictor of adverse events. However, the effect of chronic renal impairment on the long-term outcomes after PCI has not been well established. The aim of this study was to evaluate the incidence of deteriorated renal function during the chronic phase after PCI and its impact on clinical outcomes. We enrolled 282 consecutive patients who underwent PCI and had serum creatinine measured during the chronic phase (at least 3 months after PCI). We divided the study population into two groups: an advanced group that had an increase in stage of chronic kidney disease during the chronic phase, and a preserved group that included the remainder of the study population. There were 43 patients in the advanced group. We evaluated the incidence of major adverse cardiac events (MACE) that included all-cause death, nonfatal myocardial infarction, and rehospitalization with heart failure or angina pectoris. The rate of rehospitalization for heart failure and angina pectoris was significantly higher in the advanced group than in the preserved group (19.0% vs 6.8%, P < 0.01). In multivariate Cox regression analysis, the advanced group was associated with MACE (hazard ratio 3.50, 95% confidence interval 1.49-8.22, P < 0.01). Deterioration of renal function during long-term follow-up after percutaneous coronary intervention was associated with adverse cardiac events.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21822708     DOI: 10.1007/s00380-011-0177-6

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  37 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Why is chronic kidney disease the "spoiler" for cardiovascular outcomes?

Authors:  Peter A McCullough
Journal:  J Am Coll Cardiol       Date:  2003-03-05       Impact factor: 24.094

3.  Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure.

Authors:  Daniel E Forman; Javed Butler; Yongfei Wang; William T Abraham; Christopher M O'Connor; Stephen S Gottlieb; Evan Loh; Barry M Massie; Michael W Rich; Lynne Warner Stevenson; James B Young; Harlan M Krumholz
Journal:  J Am Coll Cardiol       Date:  2004-01-07       Impact factor: 24.094

4.  Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.

Authors:  Alan S Go; Jingrong Yang; Lynn M Ackerson; Krista Lepper; Sean Robbins; Barry M Massie; Michael G Shlipak
Journal:  Circulation       Date:  2006-06-05       Impact factor: 29.690

5.  Impact of chronic kidney disease on the severity of initially diagnosed coronary artery disease and the patient prognosis in the Japanese population.

Authors:  Hidenori Yagi; Makoto Kawai; Kimiaki Komukai; Takayuki Ogawa; Kosuke Minai; Tomohisa Nagoshi; Kazuo Ogawa; Hiroshi Sekiyama; Ikuo Taniguchi; Michihiro Yoshimura
Journal:  Heart Vessels       Date:  2010-12-03       Impact factor: 2.037

6.  Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study.

Authors:  Frank Stam; Coen van Guldener; Annemarie Becker; Jacqueline M Dekker; Robert J Heine; Lex M Bouter; Coen D A Stehouwer
Journal:  J Am Soc Nephrol       Date:  2005-12-28       Impact factor: 10.121

7.  Etiologies and outcome of acute renal insufficiency in older adults: a renal biopsy study of 259 cases.

Authors:  M Haas; B H Spargo; E J Wit; S M Meehan
Journal:  Am J Kidney Dis       Date:  2000-03       Impact factor: 8.860

8.  The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study.

Authors:  Yoshihiro Fukumoto; Hiroyuki Tsutsui; Miyuki Tsuchihashi; Akihiro Masumoto; Akira Takeshita
Journal:  J Am Coll Cardiol       Date:  2003-07-16       Impact factor: 24.094

9.  Renal function as a predictor of outcome in a broad spectrum of patients with heart failure.

Authors:  Hans L Hillege; Dorothea Nitsch; Marc A Pfeffer; Karl Swedberg; John J V McMurray; Salim Yusuf; Christopher B Granger; Eric L Michelson; Jan Ostergren; Jan Hein Cornel; Dick de Zeeuw; Stuart Pocock; Dirk J van Veldhuisen
Journal:  Circulation       Date:  2006-02-07       Impact factor: 29.690

10.  Revised equations for estimated GFR from serum creatinine in Japan.

Authors:  Seiichi Matsuo; Enyu Imai; Masaru Horio; Yoshinari Yasuda; Kimio Tomita; Kosaku Nitta; Kunihiro Yamagata; Yasuhiko Tomino; Hitoshi Yokoyama; Akira Hishida
Journal:  Am J Kidney Dis       Date:  2009-04-01       Impact factor: 8.860

View more
  11 in total

1.  Patient radiation dose reduction using an X-ray imaging noise reduction technology for cardiac angiography and intervention.

Authors:  Shigeru Nakamura; Tomoko Kobayashi; Atsushi Funatsu; Tadahisa Okada; Maria Mauti; Yuki Waizumi; Shinichi Yamada
Journal:  Heart Vessels       Date:  2015-04-04       Impact factor: 2.037

2.  Urinary KIM-1, NGAL and L-FABP for the diagnosis of AKI in patients with acute coronary syndrome or heart failure undergoing coronary angiography.

Authors:  Isidro Torregrosa; Carmina Montoliu; Amparo Urios; María Jesús Andrés-Costa; Carla Giménez-Garzó; Isabel Juan; María Jesús Puchades; María Luisa Blasco; Arturo Carratalá; Rafael Sanjuán; Alfonso Miguel
Journal:  Heart Vessels       Date:  2014-07-03       Impact factor: 2.037

3.  Preventive effect of oral nicorandil on contrast-induced nephropathy in patients with renal insufficiency undergoing elective cardiac catheterization.

Authors:  Yanming Fan; Qingmin Wei; Junna Cai; Yongtang Shi; Youliang Zhang; Limei Yao; Xiaogang Wang; Shupo Lin; Yilin Li; Jing Lv; Bin Zhou; Ruijuan Du
Journal:  Heart Vessels       Date:  2016-02-13       Impact factor: 2.037

4.  Increased cystatin C levels as a risk factor of cardiovascular events in patients with preserved estimated glomerular filtration rate after elective percutaneous coronary intervention with drug-eluting stents.

Authors:  Eiryu Sai; Kazunori Shimada; Katsumi Miyauchi; Yoshiyuki Masaki; Takahiko Kojima; Tadashi Miyazaki; Takeshi Kurata; Manabu Ogita; Shuta Tsuboi; Takuma Yoshihara; Tetsuro Miyazaki; Akimichi Ohsaka; Hiroyuki Daida
Journal:  Heart Vessels       Date:  2015-04-12       Impact factor: 2.037

5.  Benefits of dual-axis rotational coronary angiography in routine clinical practice.

Authors:  Ahmad Farshid; Jaya Chandrasekhar; Donald McLean
Journal:  Heart Vessels       Date:  2013-04-25       Impact factor: 2.037

6.  Elevation of urinary liver-type fatty acid-binding protein as predicting factor for occurrence of contrast-induced acute kidney injury and its reduction by hemodiafiltration with blood suction from right atrium.

Authors:  Hiromasa Katoh; Tsuyoshi Nozue; Yuya Kimura; Sei Nakata; Taku Iwaki; Mitsuhiro Kawano; Masa-Aki Kawashiri; Ichiro Michishita; Masakazu Yamagishi
Journal:  Heart Vessels       Date:  2013-04-20       Impact factor: 2.037

7.  Serum biomarkers and the prognosis of AMI patients.

Authors:  S Wei; L Mao; B Liu; L Zhong
Journal:  Herz       Date:  2013-05-08       Impact factor: 1.443

8.  Prognostic significance of renal dysfunction and its change pattern on outcomes in patients with acute coronary syndrome treated with emergent percutaneous coronary intervention.

Authors:  Kenichiro Otsuka; Kenei Shimada; Hisashi Katayama; Haruo Nakamura; Hirotoshi Ishikawa; Hisateru Takeda; Kohei Fujimoto; Noriaki Kasayuki; Minoru Yoshiyama
Journal:  Heart Vessels       Date:  2018-11-01       Impact factor: 2.037

9.  Renoprotective effect of nicorandil in patients undergoing percutaneous coronary intervention: a meta-analysis of 4 randomized controlled trials.

Authors:  Xiaobing Wang; Jin Geng; Hong Zhu; Changying Xing
Journal:  Oncotarget       Date:  2018-01-04

10.  Effect of sarpogrelate treatment on the prognosis after endovascular therapy for critical limb ischemia.

Authors:  Mitsuyoshi Takahara; Hideaki Kaneto; Naoto Katakami; Osamu Iida; Taka-Aki Matsuoka; Iichiro Shimomura
Journal:  Heart Vessels       Date:  2013-03-14       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.